W77. Optimizing Initial Therapy
Session: Premeeting Workshop: Hepatitis C Workshop
Wednesday, October 3, 2018: 8:35 AM
Room: S 156
Kristen M. Marks, MD, Division of Infectious Diseases, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY

Kristen Marks, MD, MS is Assistant Professor of Medicine and the ID Fellowship Program Director at Weill Cornell Medical College where she conducts research including clinical trials related to HIV and Hepatitis C virus (HCV) infections. She has taken a leadership role advancing the treatment of hepatitis C in people living with HIV and underserved populations at Cornell through clinical, education, and research activities. Several recent research projects have focused on HCV and drug use including her ongoing R01-funded study comparing HCV treatment delivery at a community syringe exchange program with usual care. She is the co-chair of an AIDS Clinical Trials Group (ACTG) multi-center study in development, currently serves on three ACTG hepatitis protocol teams, and is a member of the ACTG Hepatitis Transformative Science Group. She serves as co-investigator in the Cornell HIV/AIDS Clinical Trials Unit and Center for Study of Hepatitis C, where she is site PI for several treatment studies and other protocols related to HCV. She is the co-chair of IDSA/AASLD’s joint national guidelines panel for “Recommendations for testing, managing and treating hepatitis C” and also a member of New York State’s HCV guidelines panel.


Disclosures:

K. M. Marks, Gilead Sciences: Grant Investigator , Research grant . BMS: Grant Investigator , Research grant .

See more of: Hepatitis C Workshop
See more of: Premeeting Workshop

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.